Significant Ownership of AdvisorShares Trust

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for AdvisorShares Trust focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ Stefanie Little - Stefanie Little - Chief Compliance Officer
Manager location
Bethesda, MD

Follow Filing Activity

Follow AdvisorShares Trust with Pro and return when a new Schedule 13D/G filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Review Pro alert access Already have an account? Sign in and return here

Significant Ownership of AdvisorShares Trust

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SILO Silo Pharma, Inc. Common Stock, $0.0001 par value per share 6.7% $486,748 75,582 AdvisorShares Trust 30 Jun 2026
TRLV Trulieve Cannabis Corp. Subordinate Voting Shares, no par value 6.3% $122,905,306 10,641,152 AdvisorShares Trust 30 Jun 2026
QNTM Quantum Biopharma Ltd. Class B Subordinate Voting Shares, no par value 5.3% $814,256 203,564 AdvisorShares Trust 30 Jun 2026
CMND Clearmind Medicine Inc. Common Shares, no par value 4.8% $177,102 205,933 AdvisorShares Trust 30 Jun 2025
VFF Village Farms International, Inc. Common Stock, no par value 2.8% $7,135,068 -$5,269,724 3,430,321 -42% AdvisorShares Trust 30 Jun 2026
ENVB Enveric Biosciences, Inc. Common Stock, $0.01 par value 1.7% $5,601 -$61,613 16,974 -92% AdvisorShares Trust 31 Dec 2025
PBM PSYENCE BIOMEDICAL LTD. Common Shares, no par value 0.79% $15,077 26,924 AdvisorShares Trust 31 Dec 2024
IDLV Invesco Exchange-Traded Fund Trust II Invesco S&P International Developed Low Volatility ETF 0% $0 -$40,293,683 0 -100% AdvisorShares Trust 30 Sep 2025
INM InMed Pharmaceuticals Inc. Common Shares, no par value 0% 0 AdvisorShares Trust 31 Mar 2025
LSDI Lucy Scientific Discovery, Inc. Common Shares, no par value 0% 0 AdvisorShares Trust 31 Mar 2025

Schedules 13D/G Reported by AdvisorShares Trust:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .